Asset Management One Co. Ltd. Acquires 2,589 Shares of Teleflex Incorporated (NYSE:TFX)

Asset Management One Co. Ltd. increased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 15.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 19,233 shares of the medical technology company’s stock after purchasing an additional 2,589 shares during the period. Asset Management One Co. Ltd.’s holdings in Teleflex were worth $3,453,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of TFX. Janus Henderson Group PLC grew its holdings in Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after purchasing an additional 147,147 shares during the period. FMR LLC grew its holdings in Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after purchasing an additional 111,086 shares during the period. Assenagon Asset Management S.A. grew its holdings in Teleflex by 457.6% during the third quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company’s stock worth $29,755,000 after purchasing an additional 98,735 shares during the period. Point72 Asset Management L.P. grew its holdings in Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares during the period. Finally, Parkman Healthcare Partners LLC bought a new position in Teleflex during the third quarter worth about $23,778,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 3.2 %

NYSE TFX opened at $174.74 on Thursday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $165.62 and a 1-year high of $253.06. The company has a 50 day moving average of $177.41 and a 200-day moving average of $208.26. The company has a market cap of $8.12 billion, a price-to-earnings ratio of 34.74, a PEG ratio of 1.65 and a beta of 1.16.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Royal Bank of Canada cut their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Mizuho cut their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial cut their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Teleflex has an average rating of “Moderate Buy” and a consensus price target of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.